Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10273207 Covalent inhibitors of kras G12C

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Date Filed
February 7, 2018
Date of Patent
April 30, 2019
Patent Application Number
15891304
Patent Citations Received
‌
US Patent 12134620 Heterocyclic spiro compounds and methods of use thereof for the treatment of cancer
0
‌
US Patent 11358959 Benzothiophene and benzothiazole compounds and methods of use thereof
‌
US Patent 11377441 Covalent inhibitors of KRAS
‌
US Patent 11878985 Substituted quinazolines as inhibitors of KRAS G12C
0
‌
US Patent 10646488 Conjugates of cereblon binding compounds and G12C mutant KRAS, HRAS or NRAS protein modulating compounds and methods of use thereof
‌
US Patent 10689356 Inhibitors of KRAS G12C mutant proteins
‌
US Patent 10723738 Inhibitors of KRAS G12C mutant proteins
‌
US Patent 10730867 Inhibitors of KRAS G12C mutant proteins
‌
US Patent 10829458 Substituted quinazoline compounds and methods of use thereof
‌
US Patent 10858343 Inhibitors of KRAS G12C mutant proteins
•••
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
10273207
Patent Primary Examiner
‌
Golam M. Shameem

Find more entities like US Patent 10273207 Covalent inhibitors of kras G12C

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo